SAB Biotherapeutics
SABS | NASDAQ
$3.00
+$0.04 (+1.35%)
At close: Nov 16, 2026, 4:00 PM ET
$3.00
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:10 PM ET
SAB Biotherapeutics Statistics
Key statistics explainedMarket Data
$270.27M
$171.14M
0.58
586.34K
93.24M
19.75%
85.89%
NASDAQ
US78397T2024
Price Performance
18.6%
-20.4%
-15.7%
-19.8%
-14.3%
-64.7%
-97.3%
18.6%
-7.4%
-50.3%
-45.9%
Valuation
-1.79
N/A
0.02
-0.02
N/A
4,864.80
1.28
-3.65
-2.63
-4.11
N/A
-2.04
-2.10
-2.31
-56.0%
-27.4%
-38.0%
Financial Health
$104.05M
$4.92M
$104.05M
$235.64M
7.28
7.28
0.02
-0.06
-0.07
-13.86
-451.87
4.73
1
Margins & Profitability
0.0%
0.0%
0.0%
0.0%
N/A
N/A
0.0%
-38.9%
Returns
-34.2%
-40.0%
-38.4%
-38.5%
-34.2%
Historical Growth (CAGR)
-139.4%
-90.3%
N/A
67.5%
29.0%
N/A
-35.2%
-28.6%
N/A
Analyst Forecasts
Buy
4
21.1%
N/A
Mar 8, 2027
-$0.26
-43.5%
$125K
N/A
Fair Value Estimates
N/A
N/A
N/A
N/A
$12.00
300.0%
Cash Flow
$-68.18M
$-74.01M
$-102.79M
-$0.79
-$0.73
0.0%
Income Statement
$0
$-1.52M
$-85.04M
$-81.58M
$-80.52M
-$1.68
N/A
$-936.29K
86
Add to Watchlist
Select watchlists to add or remove SABS